Purple Biotech (PPBT) Earnings Date & Reports

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

PPBT is expected to report earnings to fall 22.22% to -7 cents per share on November 05

Purple Biotech PPBT Stock Earnings Reports

Q3'24

Est.

$-0.07

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.05

Q4'23

Est.

$-0.19

Q3'23

Est.

$-0.23

The last earnings report on August 16 showed earnings per share of -9 cents, beating the estimate of -11 cents. With 48.23K shares outstanding, the current market capitalization sits at 7.47M.

View a ticker or compare two or three

Compare

PPBT